Tokyo (JCN) Jan 19, 2006 - GlaxoSmithKline (GSK) has launched prescription drug Clavamox Dry Syrup in Japan. A penicillin antibiotic with beta-lactamase inhibitor, the new drug is indicated for the treatment of acute otitis media. It can exert beneficial effects with twice-a-day dosage.
